Overview

First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080

Status:
Completed

Trial end date:
2017-08-23

Target enrollment:

Participant gender:

Summary

This study is a first in human study that will investigate the safety, tolerability and pharmacokinetics of ascending single doses of BAY1817080 using a placebo controlled, randomized, single center design. In addition the influence of itraconazole and food on the pharmacokinetics of BAY1817080 will be investigated.

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Hydroxyitraconazole
Itraconazole